Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam as add-on therapy in patients with ...
Image issued by Dr. Reddy's on BSE. Dr. Reddy’s Laboratories is recalling Lot No: A1540076 of Levetiracetam 0.75% Sodium Chloride Injection, 1,000 mg/100 mL, single-dose infusion bags in the United ...
Dr Reddy’s Laboratories has announced a nationwide recall of one batch of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) in the US due to a ...
19 March 2025 UK biotech Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (I-O) and antibody drug conjugate (ADC)-based therapies, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback